Explore Applied Science, Group and more!

Tuckerman Capital led private equity group, through 1756349 Alberta, has closed the privatization of Galvanic Applied Sciences for $28.6 million.

Tuckerman Capital led private equity group, through 1756349 Alberta, has closed the privatization of Galvanic Applied Sciences for $28.6 million.

Quick Revenue Code, developer of SLYCE visual purchase app, has closed a new round of financing

Quick Revenue Code, developer of SLYCE visual purchase app, has closed a new round of financing

360incentives.com has raised $7.65 million from  OMERS Ventures, Klass Capital and Round 13 Capital

360incentives.com has raised $7.65 million from OMERS Ventures, Klass Capital and Round 13 Capital

Imaging Dynamics Company has appointed Donald Brown, Earl Lande, Murray Wigmore as new directors, replacing Garry Zurowski, Erwin Schwarz, Shameze Rampertab

Imaging Dynamics Company has appointed Donald Brown, Earl Lande, Murray Wigmore as new directors, replacing Garry Zurowski, Erwin Schwarz, Shameze Rampertab

Anges Québec and 17 member private investors have made a $1.04 million follow-on investment in AxesNetwork Solutions

Anges Québec and 17 member private investors have made a $1.04 million follow-on investment in AxesNetwork Solutions

Playerize, a social and mobile gaming monetization and user acquisition provider, has secured additional Series A from Rho Ventures and Real Ventures

Playerize, a social and mobile gaming monetization and user acquisition provider, has secured additional Series A from Rho Ventures and Real Ventures

Difference Capital has invested $2M in angel-backed Carta Solutions for 5% diluted stake

Difference Capital has invested $2M in angel-backed Carta Solutions for 5% diluted stake

iNovia Capital and OMERS Ventures have invested $1.5 million in Pressly

iNovia Capital and OMERS Ventures have invested $1.5 million in Pressly

XBiotech, a dveloper of a first-in-class monoclonal antibody (MABp1) to inhibit chronic inflammation, has closed a new round of major financing

XBiotech, a dveloper of a first-in-class monoclonal antibody to inhibit chronic inflammation, has closed a new round of major financing

IntroHive has added additional 1st round funding from Salesforce.com. Existing backers include Build Ventures, GrowthWorks Atlantic, NBIF, CIT GAP, Fortify VC

IntroHive has added additional 1st round funding from Salesforce.com. Existing backers include Build Ventures, GrowthWorks Atlantic, NBIF, CIT GAP, Fortify VC

Pinterest
Search